Today: 7 February 2026
Subscribe

Urban Outfitters stock slides despite “record” holiday sales — what spooked URBN shares

Urban Outfitters stock slides despite “record” holiday sales — what spooked URBN shares

Urban Outfitters shares fell 12% after hours Monday despite a 9% rise in holiday sales, as investors worried about profit margins and future demand. The stock touched $70.27 before recovering to $71.49. Apparel stocks broadly declined after weak forecasts from Abercrombie & Fitch and Birkenstock. Urban Outfitters opened 58 new stores and closed seven in the past eleven months.
12 January 2026
··
Marvell stock stalls even as chip ETFs rise — what’s moving MRVL now

Marvell stock stalls even as chip ETFs rise — what’s moving MRVL now

Marvell Technology shares slipped to $83.21 Monday afternoon, lagging a broader chip rally as the iShares Semiconductor ETF rose 0.7% and Broadcom gained 2.5%. Traders are watching Tuesday’s U.S. CPI data and Thursday’s Taiwan Semiconductor earnings for signals on AI demand. Marvell’s next earnings report is expected in early March. The company recently agreed to buy XConn Technologies for about $540 million.
12 January 2026
··
CrowdStrike stock slips on KeyBanc downgrade as 2026 security budget doubts surface

CrowdStrike stock slips on KeyBanc downgrade as 2026 security budget doubts surface

CrowdStrike shares fell 0.6% to $467.84 Monday after KeyBanc downgraded the stock to “Sector Weight,” citing high valuation and uncertain AI-driven security spending in 2026. The company announced a new partnership with Nord Security targeting small and midsize businesses. KeyBanc’s CIO survey suggests security budgets will trail overall IT spending next year. Other software stocks like Okta rose on the news.
12 January 2026
··
Dave Inc stock drops nearly 9% as fintech lenders slide; CPI test looms for DAVE

Dave Inc stock drops nearly 9% as fintech lenders slide; CPI test looms for DAVE

Dave Inc (DAVE.O) shares fell 8.8% to $218.29 Monday after President Trump called for a 10% cap on credit card interest rates, sparking a selloff in credit-sensitive stocks. About 1.1 million Dave shares traded by mid-afternoon. The drop mirrored declines in other fintechs, including Upstart and Affirm. Dave also faces a Justice Department complaint alleging it misled users about fees, which the company disputes.
12 January 2026
··
Arcutis Biotherapeutics stock slides after 2026 ZORYVE sales outlook; June FDA deadline in focus

Arcutis Biotherapeutics stock slides after 2026 ZORYVE sales outlook; June FDA deadline in focus

Arcutis Biotherapeutics shares fell 8.7% to $25.76 Monday after the company set a 2026 net product sales target of $455–$470 million for its ZORYVE franchise. The company reported $99.2 million in net product revenue last quarter and ended September with $191.4 million in cash. Arcutis plans to expand its sales team by 20% and expects key clinical trial data in early 2026. The stock hit a session low of $25.51.
12 January 2026
··
Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences shares fell 8.5% to $26.08 in afternoon trading after the company reported preliminary 2025 revenue near $800 million, up 94%, but warned of significant prior-period adjustments. The company also announced a partnership with Everlywell to develop a blood-based early cancer detection test, with more details expected at the JPMorgan Healthcare Conference later Monday.
12 January 2026
··
HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity shares fell about 10% Monday after the company issued a cautious initial fiscal 2027 outlook, projecting revenue between $1.38 billion and $1.41 billion and an HSA cash yield near 3.75%. The stock last traded at $84.62, down $9.53. Executives will present at the J.P. Morgan Healthcare Conference on Tuesday. The company reaffirmed its 2026 guidance.
12 January 2026
··
Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

Credo Technology shares rose 3.1% to $155.10 Monday, trading as high as $156.43 amid sector gains and anticipation of its Jan. 14 presentation at Needham’s Growth Conference. The company last reported $268 million in quarterly revenue and forecast up to $345 million for the next period. TSMC will report earnings Jan. 15, with investors watching for AI chip demand signals.
12 January 2026
···
Synchrony Financial stock slides on Trump’s 10% credit-card rate cap pitch — what investors watch next

Synchrony Financial stock slides on Trump’s 10% credit-card rate cap pitch — what investors watch next

Synchrony shares fell 8.2% to $79.76 after Donald Trump called for a one-year 10% cap on credit card interest rates, sparking fears of tighter regulation and profit declines. Analysts said such a cap would require congressional approval. Bread Financial, Capital One, and Barclays also saw declines. Separately, Synchrony expanded CareCredit integration with Fiserv’s Clover platform, now reaching over 40,000 providers.
12 January 2026
·
1 … 715 716 717 718 719 … 2,716

Stock Market Today

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop